Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IND
Biotech
FDA launches pilot program to speed up sluggish phase 1 trials
The program is part of what the FDA calls Operation Trial Blazer, announced in June, and will also include other efforts across the Department of Health and Human Services.
Darren Incorvaia
Sep 15, 2026 2:09pm
Makary FDA reforms ‘continue to move forward’ despite turmoil
May 26, 2026 10:27am
Denali ph. 1 Pompe plans hit with clinical hold
Dec 4, 2025 11:52am
FDA proposes higher fees for ph. 1 trials conducted outside of US
Dec 3, 2025 5:19pm
After delay, Coya receives FDA go-ahead for phase 2 ALS trial
Aug 25, 2025 11:04am
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm